Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of Castleman disease at low risk for HIV infection

American Journal of Clinical Pathology

Volumn 117, Issue 2, 2002, Pages 268-275

  Menke, David M ^a   Chadburn, Amy ^a   Cesarman, Ethel ^a   Green, Eric ^a   Berenson, James ^a   Said, Jonathan ^a   Tiemann, Markus ^a   Parwaresch, Reza ^a   Thome, Stephan D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Castleman disease; Human herpesvirus 8; Lymphoma

Indexed keywords

CYTOKINE; INTERLEUKIN 6; VIRUS RNA;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER RISK; CANCER SURVIVAL; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; GENOME; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE; LYMPHOCYTE; LYMPHOMA; NEUROPATHY; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT PLANNING;

COMORBIDITY; DISEASE PROGRESSION; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTERLEUKIN-6; LYMPH NODES; LYMPHOCYTES; PLASMA CELLS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; VIRAL PROTEINS;

EID: 0036320143     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/7243-AV50-KJ28-V6J9     Document Type: Article

References (40)

1. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease
2. Identification of the human 26-kd protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor
3. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
4. Interleukin-6 inhibits apoptosis of malignant plasma cells
5. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells
6. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
7. Human B-cell differentiation defined by an anti-peptide antibody and its possible role in autoantibody production
8. Diagnosis of Castleman's disease by identification of an immunophenotypically aberrant population of mantle zone B lymphocytes in paraffin-embedded lymph node biopsies
9. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease
10. HHV-8 associated with a plasmablastic variant of Castleman's disease that is linked to HHV-8-positive plasmablastic lymphoma
11. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells
12. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6
13. Involvement of human interleukin-6 in systemic manifestations of human herpesvirus type 8-associated multicentric Castleman's disease
14. Monoclonal antibody Ki-B3 detects a formalin resistant antigen on normal and neoplastic B cells
15. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations
16. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction
17. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction
18. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients
19. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
20. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
21. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
22. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: The POEMS syndrome: Report on two cases and a review of the literature
23. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
24. Cellular localisation of HHV-8 in Castleman's disease: Is there a link with lymph node vascularity?
25. Interleukin-6 gene expression in Castleman's disease
26. Immunopheno-typic analysis of mantle zone cells in hyaline vascular Castleman's disease
27. Tissue distribution of restricted leukocyte common antigen: A comprehensive study with protein- and carbohydrate-specific CD45R antibodies
28. An immunohistological and genotypic study of the plasma cell form of Castleman's disease
29. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies
30. Differential development of progenitor activity for three B-cell lineages
31. Peritoneal Ly-1 B cells: Genetic control, autoantibody production, increased lambda light chain expression
32. B-1 cells: Orthodox or conformist?
33. The B-cells that express anti-MAG antibodies in neuropathy and non-malignant IgM monoclonal gammopathy belong to the CD5 subpopulation
34. Characterization of B cells in human thymus
35. The human fetal omentum: A site of B cell generation
36. An embryonic source of Ly1 but not conventional B cells
37. A function for Ly-1+B cells
38. Multicentric angiofollicular lymph node hyperplasia in children: A clinicopathologic study of eight patients
39. The ontogeny and functional characteristics of human B-1 (CD5+ B) cells
40. CD5 B cells, a fetal B cell lineage